Purchase Order 36C26118P2657
Award Date 8/28/18
Potential Completion Date 3/31/19
Potential Value $722K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price Award Fee
Place of Performance
New York, NY 10118, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration awarded a $296,967.82 firm fixed price delivery order to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals. The order is for 16 doses of the radioligand therapy drug LUTATHERA (Lutetium Lu 177) to treat 4 patients. The contract does not utilize any set-asides and has a completion date of September 30, 2019. Advanced Accelerator Applications USA Inc. holds several federal...
- This federal contract award was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer of radiopharmaceutical products. The $145,125.64 firm fixed price delivery order is for the cancer drug LUTATHERA. The contract does not have a set-aside designation. Advanced Accelerator Applications USA Inc. has several additional federal contracts and blanket...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Advanced Accelerator Applications USA Inc., a radiopharmaceutical company that specializes in targeted radioligand therapy and nuclear medicine. The contract, valued at $149,628.56, is for the delivery of LUTATHERA LU77, a radiopharmaceutical product, to the VA. The contract was awarded through the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is a Firm Fixed Price...
- This contract award to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer, is for the delivery of the radiopharmaceutical product LUTATHERA to the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 21. The firm fixed price delivery order, valued at $326,532.69, was issued on December 17, 2018 with a completion date of April 28, 2020. The contract does not have a set-aside designation. Advanced Accelerator...
- This federal contract award to Advanced Accelerator Applications USA Inc. is for the initial four patient doses of the Lutathera radiopharmaceutical treatment for neuroendocrine cancer. The $144,400.00 firm fixed price purchase order was issued by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 23 and has a completion date of September 30, 2018. Advanced Accelerator Applications USA Inc. is a radiopharmaceutical company that...
- The U.S. Department of Veterans Affairs (VA) awarded a $5,273,418.90 Delivery Order contract to Advanced Accelerator Applications USA Inc., a subsidiary of Novartis, for the supply of PLUVICTO (lutetium Lu 177 vipivotide tetraxetan), LUTATHERA (lutetium Lu 177 dotatate), and NETSPOT (gallium Ga 68 dotatate) radiopharmaceuticals. This contract is part of a larger Indefinite Delivery Vehicle (IDV) and Blanket Purchase Agreement (BPA) held by Advanced Accelerator Applications USA Inc. with the VA...
- The Department of Veterans Affairs (VA) awarded a $112,052.25 firm fixed-price purchase order to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals. The contract is for the delivery of nuclear medicine products such as Lutetium Lu 177 Dotatate, Lutetium Lu 177 Vipivotide Tetraxetan, gallium Ga 68 dotatate, and Ga-68 Dotatate injections to VA medical centers and integrated service networks across the country. This contract is not set...
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 10 to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals. The $148,377.88 firm fixed-price purchase order is for the delivery of the drug LUTATHERA, which is used in targeted radioligand therapy and nuclear medicine. Advanced Accelerator Applications USA Inc. is a provider of radiopharmaceutical goods and...
- This federal contract award is for the delivery of the radiopharmaceutical products Lutetium Lu 177 LUTATHERA and PLUVICTO to the Veterans Integrated Service Network 10 (VISN 10) of the U.S. Department of Veterans Affairs (VA). The contract has a total ceiling value of $1,956,064.53 and an ultimate completion date of December 31, 2023. It was awarded on January 1, 2023 to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear...
- This is a $462,715.00 firm fixed price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer of radiopharmaceuticals. The contract is for the delivery of various radiopharmaceutical products including Lutetium Lu 177 Dotatate, Lutetium Lu 177 Vipivotide Tetraxetan, gallium Ga 68 dotatate, and Ga-68 Dotatate injections to VA medical centers and integrated service...